Merck & Co Inc $57.50

down -0.27


23/4/2014 06:40 PM  |  NYSE : MRK  
Industries : Drugs / Drug Manufacturers - Major
Get Trend Analysis Icon Get MRK Trend Analysis - it has underperformed the S&P 500 by 1%

Partner Headlines

  1. Gilead, Illumina Q1 Earnings Win Wall Street's Love

    IBD
  2. Drugmakers Prod European Stocks To Post-Easter Rally

    IBD
  3. Novartis, Glaxo Swap Units; Valeant Bids For Allergan

    IBD
  4. Novartis, Glaxo Swap Units; Lilly Buying Animal Biz

    IBD
  5. The Top 21 African-American CEOs In Business

    Benzinga
  6. Pfizer, AstraZeneca Rise On Report Of Merger Talks

    IBD
  7. Biohazard? Gilead Leads 5 Big-Cap Biotech Earnings

    IBD
  8. Has A Streamlined FDA Raised The Value Of Drug Stocks?

    IBD
  9. Corporate Cash Kings Escape U.S. Taxes

    FoxBusiness
  10. Market Wrap For April 14: Markets Surge on Positive Retail Data, Citi Earnings

    Benzinga
  11. Markets Falling? Get Your Defense Ready

    Benzinga
  12. No Legwork Mondays – Merck And Vioxx

    Benzinga
  13. Top 40 Upcoming Earnings Releases

    Benzinga
  14. Google Honors Chemist Percy Julian & His Contributions

    Benzinga
  15. US Stock Futures Slip Ahead Of Consumer Sentiment Report

    Benzinga
  16. Merck Hep-C Combo Scores

    IBD
  17. Merck Hep-C Combo Scores

    IBD
  18. Bill Nygren Comments on Merck

    GuruFocus
  19. HCV Rivalry Heats Up As Merck Combo Shines In Trial

    IBD
  20. Merck Hepatitis C Combo Scores 98% Cure Rate

    IBD
  21. US Stock Futures Edge Lower Ahead Of Jobless Claims Data

    Benzinga
  22. Biotechs Struggling To Find A Bottom

    Benzinga
  23. New Cholesterol Fighters To Take Center Stage At ACC

    IBD
  24. Merck Snags Baxter Executive As CFO

    FoxBusiness
  25. Merck Announces Appointment of Robert M. Davis as Chief Financial Officer; ...

    Benzinga
  26. Endocyte Price Targets Hiked On Cancer Drug News

    IBD
  27. Which Pharmas Can Keep Up Dividend-Buybacks?

    YCharts
  28. Google Honors Activist Dorothy Height & Her Contributions

    Benzinga
  29. Regulator, Trial Lift Endocyte

    IBD
  30. Abbvie Inc. (ABBV) Dividend Stock Analysis

    GuruFocus
  31. Mid-Day Market Update: Nike Drops On Cautious Forecast; Endocyte Shares ...

    Benzinga
  32. Endocyte, Merck Cancer Drug Scores Twice

    IBD
  33. Mid-Morning Market Update: Markets Open Higher; Tiffany Posts Downbeat ...

    Benzinga
  34. Benzinga's Volume Movers

    Benzinga
  35. Benzinga's Top #PreMarket Gainers

    Benzinga
  36. Gilead's HCV Challengers Near The Starting Gate

    IBD
  37. Gilead's HCV Challengers Near The Starting Gate

    IBD
  38. UPDATE: FDA Approves Merck Noxafi Injection for IV Use

    Benzinga
  39. How To Understand And Use IBD's Dividend Screens

    IBD
  40. Merck Unchanged

    Benzinga
  41. Pfizer Breast-Cancer Drug To Show If It's For Real

    IBD
  42. Top Owned Health Care Stocks of the Fourth Quarter

    GuruFocus
  43. Top Three Holdings of a Top Investment Advisory Firm

    GuruFocus
  44. Arrowhead Surges As Analysts Laud Hepatitis B Drug

    IBD
  45. Google, Ebay: Why A Top Mutual Fund Likes Them

    IBD
  46. Bristol Moving Ahead With Lung-Cancer Drug Combo

    IBD
  47. GuruFocus Names Five Dividend Growers

    GuruFocus
  48. The Top Five Dow Stocks In February

    Benzinga
  49. Qihoo, WuXi, Akorn Among Last IBD 50 Earnings Reports

    IBD
  50. Overvaluing Liquidity: Invest For The Future, Not For Today

    Benzinga
Trading Center